JP2019513821A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513821A5
JP2019513821A5 JP2019502538A JP2019502538A JP2019513821A5 JP 2019513821 A5 JP2019513821 A5 JP 2019513821A5 JP 2019502538 A JP2019502538 A JP 2019502538A JP 2019502538 A JP2019502538 A JP 2019502538A JP 2019513821 A5 JP2019513821 A5 JP 2019513821A5
Authority
JP
Japan
Prior art keywords
serotype
polypeptide
item
group
unique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019502538A
Other languages
English (en)
Japanese (ja)
Other versions
JP7164200B2 (ja
JP2019513821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/025621 external-priority patent/WO2017173415A2/en
Publication of JP2019513821A publication Critical patent/JP2019513821A/ja
Publication of JP2019513821A5 publication Critical patent/JP2019513821A5/ja
Priority to JP2022111088A priority Critical patent/JP2022130741A/ja
Application granted granted Critical
Publication of JP7164200B2 publication Critical patent/JP7164200B2/ja
Priority to JP2023152185A priority patent/JP2023166591A/ja
Priority to JP2025095460A priority patent/JP2025124888A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019502538A 2016-03-31 2017-03-31 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法 Active JP7164200B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022111088A JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201662316555P 2016-03-31 2016-03-31
US62/316,555 2016-03-31
US201662330245P 2016-05-02 2016-05-02
US62/330,245 2016-05-02
US201662372263P 2016-08-08 2016-08-08
US62/372,263 2016-08-08
US201662373807P 2016-08-11 2016-08-11
US62/373,807 2016-08-11
PCT/US2017/025621 WO2017173415A2 (en) 2016-03-31 2017-03-31 Saccharide-polypeptide conjugate compositions and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022111088A Division JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Publications (3)

Publication Number Publication Date
JP2019513821A JP2019513821A (ja) 2019-05-30
JP2019513821A5 true JP2019513821A5 (enExample) 2020-05-14
JP7164200B2 JP7164200B2 (ja) 2022-11-01

Family

ID=59965349

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019502538A Active JP7164200B2 (ja) 2016-03-31 2017-03-31 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2022111088A Revoked JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A Pending JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A Pending JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022111088A Revoked JP2022130741A (ja) 2016-03-31 2022-07-11 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2023152185A Pending JP2023166591A (ja) 2016-03-31 2023-09-20 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
JP2025095460A Pending JP2025124888A (ja) 2016-03-31 2025-06-09 サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法

Country Status (4)

Country Link
US (2) US11058757B2 (enExample)
EP (2) EP4488286A3 (enExample)
JP (4) JP7164200B2 (enExample)
WO (1) WO2017173415A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058757B2 (en) * 2016-03-31 2021-07-13 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
IL267709B2 (en) 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
GB201711637D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
GB201711635D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
CA3074706A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
HUE068482T2 (hu) * 2017-09-07 2025-01-28 Merck Sharp & Dohme Llc Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
EP3691677A4 (en) 2017-10-04 2021-07-07 Pogona, Llc COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE
EP3720483B1 (en) * 2017-12-06 2025-11-19 Merck Sharp & Dohme LLC Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
BR112020015696A2 (pt) 2018-02-05 2020-12-08 Sanofi Pasteur, Inc. Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
TW202011985A (zh) 2018-04-18 2020-04-01 韓商Ｓｋ生物科學股份有限公司 肺炎鏈球菌的莢膜多醣類以及其免疫原性接合體
EP4483896A3 (en) * 2018-07-04 2025-04-02 Vaxcyte, Inc. Improvements in immunogenic conjugates
MX2021003358A (es) 2018-09-23 2021-05-27 Biological E Ltd Polisacaridos capsulares purificados de streptococcus pneumoniae.
CA3120926A1 (en) * 2018-10-12 2020-04-16 Biological E Limited Multivalent pneumococcal polysaccharide-protein conjugate vaccine
US20220016229A1 (en) * 2018-12-12 2022-01-20 Pfizer Inc. Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
EP3897705A2 (en) * 2018-12-19 2021-10-27 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
US20220184199A1 (en) * 2019-04-10 2022-06-16 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2021014948A (es) * 2019-06-05 2022-01-24 Merck Sharp & Dohme Llc Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
US12053515B2 (en) * 2020-08-10 2024-08-06 Inventprise, Inc. Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
CA3200602A1 (en) * 2020-11-04 2022-05-12 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
CN115671274B (zh) * 2022-09-29 2024-03-12 普大生物科技(泰州)有限公司 一种载体蛋白与多糖共价键连接成结合物的方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221906A (en) 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4242501A (en) 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
CA2059693C (en) 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
JP4057576B2 (ja) 2004-10-08 2008-03-05 財団法人浜松科学技術研究振興会 靴底用中敷
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
KR101446238B1 (ko) * 2006-08-07 2014-10-01 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 단백질 매트릭스 백신 및 그의 제조방법 및 백신 투여방법
TW201136603A (en) * 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20130142A1 (it) * 2013-01-31 2014-08-01 Biosynth Srl Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
EP4272750A3 (en) * 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
CN104069488A (zh) * 2013-03-29 2014-10-01 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
WO2015006555A2 (en) 2013-07-10 2015-01-15 Sutro Biopharma, Inc. Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
KR20160040556A (ko) 2013-07-11 2016-04-14 노파르티스 아게 미생물 트랜스글루타미나제를 사용한 리신-특이적 화학효소적 단백질 변형
CN116603058A (zh) 2015-03-26 2023-08-18 Gpn疫苗有限公司 链球菌疫苗
RS61440B1 (sr) * 2015-06-23 2021-03-31 Biological E Ltd Multivalentna pneumokokna konjugatna vakcina
KR20250058066A (ko) 2015-07-21 2025-04-29 화이자 인코포레이티드 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
US11058757B2 (en) * 2016-03-31 2021-07-13 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
CN109789198B (zh) * 2016-09-30 2024-08-16 生物E有限公司 包含多糖-蛋白缀合物的多价肺炎球菌疫苗组合物
EP3691677A4 (en) * 2017-10-04 2021-07-07 Pogona, Llc COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE

Similar Documents

Publication Publication Date Title
AU2018225099B2 (en) Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugates
JP7690523B2 (ja) 多価肺炎球菌多糖体－タンパク質複合体組成物
KR102225282B1 (ko) 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
Khatun et al. An overview of structural features of antibacterial glycoconjugate vaccines that influence their immunogenicity
AU2019215212B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
TWI789357B (zh) 多價肺炎球菌多醣-蛋白質共軛物組成物(二)
JP2022105155A (ja) 多糖類－タンパク質コンジュゲートを含む多価肺炎球菌ワクチン組成物
ES2546186T3 (es) Procedimiento de fabricación de vacunas
JP2020533438A5 (enExample)
CN103402544A (zh) 缀合方法
MX2012010388A (es) Proceso de conjugacion de polisacaridos bacterianos con proteinas portadoras.
JP2018516962A5 (enExample)
KR20130098362A (ko) 면역원성 조성물
JP2018518512A (ja) 多価肺炎球菌コンジュゲートワクチン
Lockhart Conjugate vaccines
BR112015016817B1 (pt) métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica
KR20200018784A (ko) 신규 다가 다당류-단백질 접합체 백신 조성물 및 이의 제형
EP3817775B1 (en) Improvements in immunogenic conjugates
AU2020355401B2 (en) Neisseria meningitidis compositions and methods thereof
HK40117919A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
HK40074440B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
RU2023120100A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
HK40023130B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
RU2020112314A (ru) Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель
HK40050310A (en) Improvements in immunogenic conjugates